Evolus (EOLS) FCF Margin (2019 - 2026)

Evolus (EOLS) posted FCF Margin of 13.62% for Q1 2026, down 201.34% on a QoQ basis from 13.44% in Q4 2025, and up 965.0% year-over-year from 1.28% in Q1 2025.

Evolus (EOLS) FCF Margin (2019 - 2026) Analysis & Trends

Evolus' FCF Margin history runs 8 years deep, the most recent figure standing at 13.62% for Q1 2026.

  • Quarterly FCF Margin rose 965.0% year-over-year to 13.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.68% (down 477.0% YoY) and the FY2025 annual result came in at 15.91%, down 860.0% from the prior year.
  • FCF Margin was 13.62% for Q1 2026 at Evolus, down from 13.44% in the prior quarter.
  • Across five years, FCF Margin topped out at 13.44% in Q4 2025 and bottomed at 112.69% in Q1 2022.
  • A 5-year average of 25.98% and a median of 22.09% in 2022 frame the typical range for FCF Margin.
  • Peak annual rise in FCF Margin reached 7124 bps in 2022, while the deepest fall reached 11901 bps in 2022.
  • Evolus' FCF Margin stood at 22.09% in 2022, then surged by 105 bps to 1.08% in 2023, then soared by 411 bps to 5.54% in 2024, then soared by 143 bps to 13.44% in 2025, then sank by 201 bps to 13.62% in 2026.
  • Business Quant data shows EOLS's FCF Margin at 13.62% in Q1 2026, 13.44% in Q4 2025, and 23.01% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -5.22%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 12.86%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5.35%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 46.54%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 9.93%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 17.73%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.77%
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn -13.62%

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.62%
Dec 31, 2025 13.44%
Sep 30, 2025 -23.01%
Jun 30, 2025 -39.77%
Mar 31, 2025 -23.28%
Dec 31, 2024 5.54%
Sep 30, 2024 -8.88%
Jun 30, 2024 -11.28%
Mar 31, 2024 -18.32%
Dec 31, 2023 1.08%
Sep 30, 2023 -2.87%
Jun 30, 2023 -27.51%
Mar 31, 2023 -49.89%
Dec 31, 2022 -22.09%
Sep 30, 2022 -51.32%
Jun 30, 2022 -57.27%
Mar 31, 2022 -112.69%
Dec 31, 2021 -24.45%
Sep 30, 2021 -122.56%
Jun 30, 2021 61.74%